Related Experiment Video
Updated: Jun 8, 2026
Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
[Optimization of enuresis therapy in children using transcranial magnetotherapy]
Insights
This study shows that adding transcranial bitemporal magnetotherapy (TcMT) to reduced medication significantly improves outcomes for children with nocturnal enuresis (NE). TcMT effectively reduces symptoms and reliance on medication.
Area of Science:
- Pediatric Neurology
- Complementary Medicine
Context:
- Nocturnal enuresis (NE) affects many children, often requiring pharmacological treatment.
- Current treatments may have side effects or reduced efficacy over time.
Purpose:
- To evaluate the efficacy of transcranial bitemporal magnetotherapy (TcMT) as an adjunct to reduced-dose medication for childhood nocturnal enuresis.
Summary:
- A study involving 58 children with NE compared a group receiving reduced driptan and TcMT to a control group receiving placebo TcMT and standard therapy.
- The TcMT group showed a 1.3-fold reduction in imperative voiding symptoms and a 1.7-fold decrease in enuresis episodes.
- Significant improvements were also observed in bladder volume (1.9-fold) and vegetative status, as measured by cardiointervalography, after 6.8 months.
Impact:
- Adjunctive TcMT enhances clinical outcomes in NE patients.
- TcMT allows for a 2-fold reduction in the pharmacological burden, suggesting a safer treatment approach.
- This non-invasive therapy offers a promising alternative or supplement to traditional NE treatments.
Abstract:
A total of 58 children (age from 6 to 14 years) suffering from nocturnal enuresis (NE) were divided into two groups. The study group received basic therapy (driptan dose was reduced to 2.5 mg twice a day) in combination with transcranial bitemporal magnetotherapy (TcMT). The control group received placebo TcMT and basic therapy. It is shown that addition of TcMT to reduced basic therapy lowered the score of imperative voiding symptoms 1.3-fold, number of enuresis patients 1.7-fold, volume of the bladder 6.8 months after the treatment 1.9-fold, corrected vegetative status and activity of the subcortical nervous center in 24% children according to cardiointervalography versus the controls. Thus, TcMT improves clinical effect in NE patients in 2-fold reduction of pharmacological burden.
More Related Videos
11:17Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
06:05Employing Transcranial Magnetic Stimulation in a Resource Limited Environment to Establish Brain-Behavior Relationships
Published on: April 20, 2022